Oracea
Oracea Official FDA information, side effects and uses.
Posted by Oracea (Oracea) on Tue, 28 Aug 2007 23:16:04 +0000
NEWTOWN, Pa.----CollaGenex Pharmaceuticals, Inc. today announced results of a Phase 2 dose-finding study designed to evaluate the safety and efficacy of Col-118 for the treatment of erythema.
CollaGenex Pharmaceuticals Reports Financial Results for the Second Quarter and First Half of 2007 (Business Wire via Yahoo! Finance)
NEWTOWN, Pa.----CollaGenex Pharmaceuticals, Inc. today reported financial results for the second quarter and six months ended June 30, 2007.
Ad hoc: MediGene AG: Decision About European Marketing Authorization for Oracea® Postponedto 2008 Börsennachrichten - ... (Stock World)
Martinsried/Munich - July 30, 2007. MediGene AG (Frankfurt, Prime Standard: MDG) has been informed by CollaGenex Pharmaceuticals Inc., that the decision about the European marketing authorization for the drug Oracea® for the treatment of the skin disease rosacea has been postponed.
German Stocks Climb; MAN, DaimlerChrysler, BMW Pace the Advance (Bloomberg.com)
July 31 (Bloomberg) -- Germany's benchmark DAX Index posted the biggest one-day gain in more than two weeks. MAN AG paced the advance after Europe's third-largest truckmaker reported its 16th consecutive profit increase.
Deutsche Boerse, Deutz, Infineon, MAN: German Equity Preview (Bloomberg.com)
July 31 (Bloomberg) -- The following stocks may rise or fall in German markets. Germany's X-DAX Index climbed 0.9 percent to 7529.98. The index provides an estimate of the DAX Index, based on trading in DAX futures after the Xetra electronic market closes.
